These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38453543)

  • 41. Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.
    Salvi M; Trashi E; Marin O; Negro A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2012 Feb; 418(1):156-60. PubMed ID: 22248692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death.
    Reimer L; Vesterager LB; Betzer C; Zheng J; Nielsen LD; Kofoed RH; Lassen LB; Bølcho U; Paludan SR; Fog K; Jensen PH
    Neurobiol Dis; 2018 Jul; 115():17-28. PubMed ID: 29501855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
    Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
    Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.
    Jensen PH; Hager H; Nielsen MS; Hojrup P; Gliemann J; Jakes R
    J Biol Chem; 1999 Sep; 274(36):25481-9. PubMed ID: 10464279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production.
    Kofoed RH; Zheng J; Ferreira N; Lykke-Andersen S; Salvi M; Betzer C; Reimer L; Jensen TH; Fog K; Jensen PH
    Neurobiol Dis; 2017 Oct; 106():49-62. PubMed ID: 28648742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.
    McFarland MA; Ellis CE; Markey SP; Nussbaum RL
    Mol Cell Proteomics; 2008 Nov; 7(11):2123-37. PubMed ID: 18614564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections.
    Ulusoy A; Phillips RJ; Helwig M; Klinkenberg M; Powley TL; Di Monte DA
    Acta Neuropathol; 2017 Mar; 133(3):381-393. PubMed ID: 28012041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.
    Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M
    Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
    Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
    J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diet-induced obesity accelerates the onset of terminal phenotypes in α-synuclein transgenic mice.
    Rotermund C; Truckenmüller FM; Schell H; Kahle PJ
    J Neurochem; 2014 Dec; 131(6):848-58. PubMed ID: 24995537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.
    Sorrentino ZA; Giasson BI; Chakrabarty P
    Acta Neuropathol; 2019 Jul; 138(1):1-21. PubMed ID: 30798354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease.
    Oueslati A; Paleologou KE; Schneider BL; Aebischer P; Lashuel HA
    J Neurosci; 2012 Feb; 32(5):1536-44. PubMed ID: 22302797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.
    Rey NL; Bousset L; George S; Madaj Z; Meyerdirk L; Schulz E; Steiner JA; Melki R; Brundin P
    Acta Neuropathol Commun; 2019 Dec; 7(1):221. PubMed ID: 31888771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.
    Volpicelli-Daley LA; Abdelmotilib H; Liu Z; Stoyka L; Daher JP; Milnerwood AJ; Unni VK; Hirst WD; Yue Z; Zhao HT; Fraser K; Kennedy RE; West AB
    J Neurosci; 2016 Jul; 36(28):7415-27. PubMed ID: 27413152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult.
    Henderson MX; Sedor S; McGeary I; Cornblath EJ; Peng C; Riddle DM; Li HL; Zhang B; Brown HJ; Olufemi MF; Bassett DS; Trojanowski JQ; Lee VMY
    Neuron; 2020 Mar; 105(5):822-836.e7. PubMed ID: 31899072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.
    Richter F; Subramaniam SR; Magen I; Lee P; Hayes J; Attar A; Zhu C; Franich NR; Bove N; De La Rosa K; Kwong J; Klärner FG; Schrader T; Chesselet MF; Bitan G
    Neurotherapeutics; 2017 Oct; 14(4):1107-1119. PubMed ID: 28585223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
    Oueslati A
    J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.